Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
You’re invited to join our “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now. MGFA is offering this online webinar program series to anyone interested in learning more about this ongoing MG research in investigative therapies. We hope you’ll register for the latest update.
Update of MuSK Myasthenia Gravis Phase 1 Clinical Trial (MusCAARTes)
Oct 11th, 2022 | 2pm Eastern, 11am Pacific
- Review of data that supported IND submission and clearance by the FDA
- Discuss the purpose of clinical trials
- Present the design of the MusCAARTes Phase 1 clinical trial for patients with MuSK Myasthenia Gravis
The presenter will be David Chang, M.D., M.P.H., Chief Medical Officer at Cabaletta Bio.
Register for This Webinar
National Presenting Partners